Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

ClinicalTrials.gov ID: NCT01461096

Public ClinicalTrials.gov record NCT01461096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men and Women

Study identification

NCT ID
NCT01461096
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
575 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Vaccine for Female Participants Only Biological
  • Placebo Vaccine for Male Participants Only Biological
  • Quadrivalent HPV Vaccine Biological

Biological

Eligibility (public fields only)

Age range
27 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2012
Primary completion
Nov 30, 2015
Completion
Dec 31, 2015
Last update posted
Nov 1, 2021

2012 – 2016

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
UCLA CARE Center CRS Los Angeles California 90035
Stanford AIDS Clinical Trials Unit CRS Palo Alto California 94304-5350
UCSD Antiviral Research Center CRS San Diego California 92103
Ucsf Hiv/Aids Crs San Francisco California 94110
University of Colorado Hospital CRS Aurora Colorado 80045
Denver Public Health CRS Denver Colorado 80204
Northwestern University CRS Chicago Illinois 60611
Rush University CRS Chicago Illinois 60612
Massachusetts General Hospital CRS (MGH CRS) Boston Massachusetts 02114
Boston Medical Center CRS Boston Massachusetts 02118
Beth Israel Deaconess Med. Ctr., ACTG CRS Boston Massachusetts 02215
Washington University Therapeutics (WT) CRS St Louis Missouri 63110-1010
New Jersey Medical School Clinical Research Center CRS Newark New Jersey 07103
Weill Cornell Chelsea CRS New York New York 10011
NY Univ. HIV/AIDS CRS New York New York 10016
Columbia P&S CRS New York New York 10032-3732
University of Rochester Adult HIV Therapeutic Strategies Network CRS Rochester New York 14642
Chapel Hill CRS Chapel Hill North Carolina 27599
Cincinnati Clinical Research Site Cincinnati Ohio 45219
University of Pittsburgh CRS Pittsburgh Pennsylvania 15213
The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence Rhode Island 02906
Houston AIDS Research Team CRS Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01461096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2021 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01461096 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →